Clinical Trial Update: Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of IxCell hUC-MSC-O for knee osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• IxCell hUC-MSC-O (human umbilical cord-derived mesenchymal stem cell product)

Snippet

Sponsor: Shanghai IxCell Biotechnology Co., LTD | Conditions: Knee Osteoarthritis | Phase 3 | Status: RECRUITING